Generic and brand-name drugs T

Generic and brand-name drugs T: Composition, drug form and content, indications, contraindications, precautions, unwanted effects, dosage and administration, interactions, storage

Trajenta: Antidiabetic drug independent with renal function

Trajenta is indicated for the treatment of type 2 diabetes mellitus (T2DM) in adult patients to improve glycemic control, glycemic control monotherapy, or in combination with metformin, with pioglitazone or a sulfonylurea, with insulin.

Trajenta Duo: A combination antidiabetic drug

Trajenta Duo is indicated for the treatment of type 2 diabetes mellitus and should be treated concomitantly with linagliptin and metformin. Trajenta Duo is indicated in combination with a sulphonylurea (ie a 3-drug regimen) along with an appropriate regimen.

Troxevasin: Medicine to treat chronic venous insufficiency

Troxevasin is indicated for the relief of swelling and symptoms associated with chronic venous insufficiency, along with elastic compression stockings in varicose dermatitis, in the combined treatment of varicose ulcers.

Twinrix: Vaccine against hepatitis A and B

Twinrix immunizes against hepatitis A and hepatitis B infections by generating specific antibodies to HAV and anti-HBs. Twinrix is indicated for immunocompromised individuals who are at risk for both hepatitis A and hepatitis B infection.

Twynsta: medicine to treat high blood pressure

Twynsta for the treatment of essential hypertension. Patients taking telmisartan and amlodipine individually can be substituted with Twynsta containing the same strength and composition of drugs.